Your browser doesn't support javascript.
Placental Tissue Destruction and Insufficiency From COVID-19 Causes Stillbirth and Neonatal Death From Hypoxic-Ischemic Injury.
Schwartz, David A; Avvad-Portari, Elyzabeth; Babál, Pavel; Baldewijns, Marcella; Blomberg, Marie; Bouachba, Amine; Camacho, Jessica; Collardeau-Frachon, Sophie; Colson, Arthur; Dehaene, Isabelle; Ferreres, Joan Carles; Fitzgerald, Brendan; Garrido-Pontnou, Marta; Gergis, Hazem; Hargitai, Beata; Helguera-Repetto, A Cecilia; Holmström, Sandra; Irles, Claudine Liliane; Leijonhfvud, Åsa; Libbrecht, Sasha; Marton, Tamás; McEntagart, Noel; Molina, James T; Morotti, Raffaella; Nadal, Alfons; Navarro, Alexandra; Nelander, Maria; Oviedo, Angelica; Otani, Andre Ricardo Oyamada; Papadogiannakis, Nikos; Petersen, Astrid C; Roberts, Drucilla J; Saad, Ali G; Sand, Anna; Schoenmakers, Sam; Sehn, Jennifer K; Simpson, Preston R; Thomas, Kristen; Valdespino-Vázquez, M Yolotzin; van der Meeren, Lotte E; Van Dorpe, Jo; Verdijk, Robert M; Watkins, Jaclyn C; Zaigham, Mehreen.
  • Schwartz DA; From Schwartz is in consultative practice of Perinatal Pathology, Atlanta, Georgia.
  • Avvad-Portari E; From the Department of Pathology, Fernandes Figueira Institute, FIOCRUZ, Rio de Janeiro, Brazil (Avvad-Portari).
  • Babál P; From the Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia (Babál).
  • Baldewijns M; From the Department of Pathology, University Hospitals Leuven, Leuven, Belgium (Baldewijns).
  • Blomberg M; From the Department of Obstetrics and Gynecology and the Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden (Blomberg).
  • Bouachba A; From the Institut de Pathologie Multisite des Hospices Civils de Lyon, Lyon, France (Bouachba).
  • Camacho J; From SOFFOET-Société Française de Fœtopathologie, Paris, France (Bouachba, Collardeau-Frachon).
  • Collardeau-Frachon S; From the Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain (Camacho, Garrido-Pontnou, Navarro).
  • Colson A; From SOFFOET-Société Française de Fœtopathologie, Paris, France (Bouachba, Collardeau-Frachon).
  • Dehaene I; From the Department of Pathology, Hopital Femme-Mère Enfant, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Bron, France (Collardeau-Frachon).
  • Ferreres JC; From the Department of Obstetrics, Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain, Brussels, Belgium (Colson).
  • Fitzgerald B; From the Department of Obstetrics and Gynaecology (Dehaene), Ghent University Hospital, Ghent, Belgium.
  • Garrido-Pontnou M; From the Pathology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Barcelona, Spain (Ferreres).
  • Gergis H; From the Department of Morphological Sciences, School of Medicine, Universitat Autònoma de Barcelona, Sabadell, Spain (Ferreres).
  • Hargitai B; From the Department of Pathology, Cork University Hospital, Wilton, Cork, Republic of Ireland (Fitzgerald).
  • Helguera-Repetto AC; From the Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain (Camacho, Garrido-Pontnou, Navarro).
  • Holmström S; From the Department of Morphological Sciences, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain (Garrido-Pontnou).
  • Irles CL; From the Department of Obstetrics and Gynaecology, Doncaster and Bassetlaw NHS Teaching Hospitals, Women's Hospital, Doncaster, United Kingdom (Gergis).
  • Leijonhfvud Å; From the Division of Perinatal Pathology, Department of Cellular Pathology, Birmingham Women's and Children's Hospital, NHS Foundation Trust, Birmingham, United Kingdom (Hargitai).
  • Libbrecht S; From the Department of Immunobiochemistry (Helguera-Repetto), National Institute of Perinatology, Mexico City, Mexico.
  • Marton T; From the Department of Obstetrics and Gynaecology, Halland Hospital, Varberg, Sweden (Holmström).
  • McEntagart N; From the Department of Physiology and Cellular Development, National Institute of Perinatology "Isidro Espinosa de los Reyes," Mexico City, Mexico (Irles).
  • Molina JT; From the Department of Obstetrics and Gynaecology, Helsingborg Hospital, Department of Clinical Science Helsingborg, Lund University, Lund, Sweden (Leijonhfvud).
  • Morotti R; From the Department of Pathological Anatomy, Antwerp University Hospital, Edegem, Belgium (Libbrecht).
  • Nadal A; From the Cellular Pathology Department, Birmingham Women's Hospital, Birmingham, United Kingdom (Marton).
  • Navarro A; From Histopathology, Rotunda Hospital, Dublin, Republic of Ireland (McEntagart).
  • Nelander M; From Pathology and Laboratory Medicine (Molina).
  • Oviedo A; From the Department of Pathology and Pediatrics, Autopsy Service, Yale University School of Medicine, New Haven, Connecticut (Morotti).
  • Otani ARO; From the Pathology Department, Hospital Clínic, Barcelona, Spain (Nadal).
  • Papadogiannakis N; From the Department of Basic Clinical Practice, School of Medicine, Universitat de Barcelona, and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (Nadal).
  • Petersen AC; From the Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain (Camacho, Garrido-Pontnou, Navarro).
  • Roberts DJ; From the Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden (Nelander).
  • Saad AG; From the Department of Pathology and Laboratory Medicine, Burrell College of Osteopathic Medicine, Las Cruces, New Mexico (Oviedo).
  • Sand A; From Laboratório Ferdinando Costa, São Paulo, Brazil (Otani).
  • Schoenmakers S; From the Department of Laboratory Medicine, Division of Pathology (Papadogiannakis).
  • Sehn JK; From the Departments of Pathology (Papadogiannakis), Karolinska University Hospital, Stockholm, Sweden.
  • Simpson PR; From the Department of Pathology, Aalborg University Hospital, Aalborg, Denmark (Petersen).
  • Thomas K; From the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (Roberts, Watkins).
  • Valdespino-Vázquez MY; From Pediatric Pathology and Neuropathology, Department of Pathology, University of Miami Miller School of Medicine/Jackson Health System/Holtz Children's Hospital, Miami, Florida (Saad).
  • van der Meeren LE; From the Department of Women's and Children's Health (Sand), Karolinska Institute, Stockholm, Sweden.
  • Van Dorpe J; From the Department of Obstetrics and Gynaecology, Karolinska University Hospital, Solna, Stockholm, Sweden (Sand).
  • Verdijk RM; From the Department of Obstetrics and Gynaecology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands (Schoenmakers, Verdijk).
  • Watkins JC; From the Department of Pathology, St Louis University School of Medicine, St Louis, Missouri (Sehn).
  • Zaigham M; From the Department of Pathology (Simpson), CHRISTUS Hospital St Elizabeth, Beaumont, Texas.
Arch Pathol Lab Med ; 146(6): 660-676, 2022 06 01.
Article in English | MEDLINE | ID: covidwho-1876076
ABSTRACT
CONTEXT.­ Perinatal death is an increasingly important problem as the coronavirus disease 2019 (COVID-19) pandemic continues, but the mechanism of death has been unclear. OBJECTIVE.­ To evaluate the role of the placenta in causing stillbirth and neonatal death following maternal infection with COVID-19 and confirmed placental positivity for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). DESIGN.­ Case-based retrospective clinicopathologic analysis by a multinational group of 44 perinatal specialists from 12 countries of placental and autopsy pathology findings from 64 stillborns and 4 neonatal deaths having placentas testing positive for SARS-CoV-2 following delivery to mothers with COVID-19. RESULTS.­ Of the 3 findings constituting SARS-CoV-2 placentitis, all 68 placentas had increased fibrin deposition and villous trophoblast necrosis and 66 had chronic histiocytic intervillositis. Sixty-three placentas had massive perivillous fibrin deposition. Severe destructive placental disease from SARS-CoV-2 placentitis averaged 77.7% tissue involvement. Other findings included multiple intervillous thrombi (37%; 25 of 68) and chronic villitis (32%; 22 of 68). The majority (19; 63%) of the 30 autopsies revealed no significant fetal abnormalities except for intrauterine hypoxia and asphyxia. Among all 68 cases, SARS-CoV-2 was detected from a body specimen in 16 of 28 cases tested, most frequently from nasopharyngeal swabs. Four autopsied stillborns had SARS-CoV-2 identified in internal organs. CONCLUSIONS.­ The pathology abnormalities composing SARS-CoV-2 placentitis cause widespread and severe placental destruction resulting in placental malperfusion and insufficiency. In these cases, intrauterine and perinatal death likely results directly from placental insufficiency and fetal hypoxic-ischemic injury. There was no evidence that SARS-CoV-2 involvement of the fetus had a role in causing these deaths.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Placenta / Pregnancy Complications, Infectious / Perinatal Death / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans / Infant, Newborn / Pregnancy Language: English Journal: Arch Pathol Lab Med Year: 2022 Document Type: Article Affiliation country: Arpa.2022-0029-SA

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Placenta / Pregnancy Complications, Infectious / Perinatal Death / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans / Infant, Newborn / Pregnancy Language: English Journal: Arch Pathol Lab Med Year: 2022 Document Type: Article Affiliation country: Arpa.2022-0029-SA